InvestorsHub Logo

Pat Torney

04/25/17 12:42 PM

#2613 RE: Gpheart2016 #2612

I agree with this prediction. I don't think this company will see any significant jumps with news from phase II. Most investors have no confidence in the current leadership to create a profitable company.

I have a relatively small amount of shares that I am holding onto that I am willing to lose completely. My only hope is that the BOD will get rid of PN and find a real CEO who knows how to run a real company. If that happens, I may buy more. If not, I fully anticipate my shares end up worthless, but I have high hopes of a max pps of maybe $5 if they get FDA approval. There may be a buyout at that point from a small to medium sized pharma company, but I don't think any big pharma has any interest in this company.